top of page
  • Writer's pictureDahlia Foundation

TRENDINGShortage of critical medicines hits drug-resistant TB patients


MUMBAI: In the city and various regions across the country, ..

Several activist and patient groups wrote to the union health minister, Mansukh Mandaviya, earlier this week, appealing for their intervention to expedite the procurement of these medications


Several activist and patient groups wrote to the union health minister, Mansukh Mandaviya, earlier this week, appealing for their intervention to expedite the procurement of these medications. Anti-TB medications, including Linezolid, Clofazimine, Cycloserine and Moxifloxacin, have been in short supply for over a month at both public treatment centres and private pharmacies. Shortage for newer drugs such as Delamanid is emerging too. The Central TB Division (CTD), responsible for procuring and distributing these medicines to all states, reportedly did not initiate tenders earlier this year, resulting in these stockouts. This shortage is particularly noticeable in cities such as Mumbai, which carries a significant burden of drug-resistant TB cases. Maharashtra has nearly 10,000 multi-drug resistant TB patients, of whom 5,000-odd are from the city alone. While BMC officials downplayed the shortage, stating they currently have stocks and are prepared to acquire medicines for the upcoming months, activist Ganesh Acharya said patients are encountering difficulties. They are being directed to source medicines from private pharmacies.



0 views0 comments

Comments


bottom of page